Antikroppar mot citrullinerade proteiner/peptider – ett genombrott inom reumatologisk diagnostik.
Rönnelid J, Klareskog L , Skogh T och Svensson B.
Review. Läkartidningen 2004:50;4092-96
Kategori: Publikationer
Health status as measured by SF-36 reflects changes and predicts outcome in chronic musculoskeletal pain: a 3-year follow up study in the general population.
Bergman S, Jacobsson LT, Herrström P, Petersson IF.
Pain. 2004 Mar;108(1-2):115-23
J Rheumatol. 2004 Feb;31(2):214-22.PMID: 14760787
Scand J Rheumatol. 2004;33(3):154-61. doi: 10.1080/03009740410006862.PMID: 15228185 Clinical Trial.
J Rheumatol. 2003 Dec;30(12):2590-6.PMID: 14719199
Validation of the Rheumatoid and Arthritis Outcome Score (RAOS) for the lower extremity.
Bremander AB, Petersson IF, Roos EM.
Health Qual Life Outcomes. 2003 Oct 17;1:55.
Clin Exp Rheumatol. 2003 May-Jun;21(3):327-32.PMID: 12846051 Clinical Trial.
Scand J Rheumatol. 2003;32(3):131-7. doi: 10.1080/03009740310002452.PMID: 12892248 Clinical Trial.
Chronic widespread pain: a three year followup of pain distribution and risk factors.
Bergman S, Herrström P, Jacobsson LT, Petersson IF.
J Rheumatol. 2002 Apr;29(4):818-25.
Chronic musculoskeletal pain, prevalence rates, and sociodemographic associations in a Swedish population study.
Bergman S, Herrström P, Högström K, Petersson IF, Svensson B, Jacobsson LT.
J Rheumatol. 2001 Jun;28(6):1369-77.